SE421424B - Analogiforfarande for framstellning av lysergsyraamider - Google Patents

Analogiforfarande for framstellning av lysergsyraamider

Info

Publication number
SE421424B
SE421424B SE7301353A SE7301353A SE421424B SE 421424 B SE421424 B SE 421424B SE 7301353 A SE7301353 A SE 7301353A SE 7301353 A SE7301353 A SE 7301353A SE 421424 B SE421424 B SE 421424B
Authority
SE
Sweden
Prior art keywords
amamids
preparation
analogy procedure
lyric acid
lyric
Prior art date
Application number
SE7301353A
Other languages
English (en)
Inventor
E Mago
T Balogh
E Uskert
J Borsi
L Wolf
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HUGO001186 external-priority patent/HU164051B/hu
Priority claimed from HUGO001187 external-priority patent/HU163546B/hu
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of SE421424B publication Critical patent/SE421424B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06Lysergic acid amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06Lysergic acid amides
    • C07D457/08Lysergic acid amides in which the amide nitrogen is a member of a heterocyclic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE7301353A 1972-02-04 1973-01-31 Analogiforfarande for framstellning av lysergsyraamider SE421424B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HUGO001186 HU164051B (sv) 1972-02-04 1972-02-04
HUGO001187 HU163546B (sv) 1972-02-04 1972-02-04

Publications (1)

Publication Number Publication Date
SE421424B true SE421424B (sv) 1981-12-21

Family

ID=26318474

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7301353A SE421424B (sv) 1972-02-04 1973-01-31 Analogiforfarande for framstellning av lysergsyraamider

Country Status (20)

Country Link
JP (1) JPS5221516B2 (sv)
AU (1) AU475943B2 (sv)
BE (1) BE794888A (sv)
BG (1) BG22832A3 (sv)
CA (1) CA994342A (sv)
CH (1) CH589079A5 (sv)
CS (1) CS191212B2 (sv)
DD (1) DD104299A5 (sv)
DE (1) DE2305514A1 (sv)
DK (1) DK141531B (sv)
EG (1) EG10823A (sv)
FI (1) FI54118C (sv)
FR (1) FR2190440B1 (sv)
GB (1) GB1401155A (sv)
IL (1) IL41409A (sv)
NL (1) NL178256C (sv)
NO (1) NO133670C (sv)
SE (1) SE421424B (sv)
SU (1) SU468419A3 (sv)
YU (1) YU36730B (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU169073B (sv) * 1974-05-28 1976-09-28
HU168914B (sv) * 1974-07-30 1976-08-28
HU172649B (hu) * 1975-04-24 1978-11-28 Gyogyszerkutato Intezet Sposob poluchenija novykh biologicheski aktivnykh lizergamidov
DE2802023A1 (de) * 1977-01-28 1978-08-03 Sandoz Ag Neue ergotderivate, ihre herstellung und verwendung
JPH0438472U (sv) * 1990-07-31 1992-03-31
IT1260156B (it) * 1992-08-03 1996-03-28 Fidia Spa Derivati dell'acido neuraminico
KR20140042868A (ko) * 2011-06-23 2014-04-07 맵 파마슈티컬스, 인코포레이티드 신규한 플루오로에르골린 유사체

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH475252A (de) * 1966-02-08 1969-07-15 Sandoz Ag Verfahren zur Herstellung neuer Lysergsäure-Derivate
AT291446B (de) * 1968-11-22 1971-07-12 Richter Gedeon Vegyeszet Verfahren zur Herstellung von neuen Apovincaminsäureamiden

Also Published As

Publication number Publication date
JPS4886900A (sv) 1973-11-15
YU26673A (en) 1982-02-25
DD104299A5 (sv) 1974-03-05
AU5163373A (en) 1974-08-01
FI54118B (fi) 1978-06-30
DK141531C (sv) 1980-10-06
EG10823A (en) 1976-07-31
SU468419A3 (ru) 1975-04-25
IL41409A (en) 1977-04-29
BE794888A (fr) 1973-05-29
BG22832A3 (bg) 1977-04-20
NL178256B (nl) 1985-09-16
NL7301369A (sv) 1973-08-07
IL41409A0 (en) 1973-03-30
GB1401155A (en) 1975-07-16
NO133670C (sv) 1976-06-09
YU36730B (en) 1984-08-31
CH589079A5 (sv) 1977-06-30
AU475943B2 (en) 1976-09-09
DE2305514A1 (de) 1973-08-16
JPS5221516B2 (sv) 1977-06-10
FI54118C (fi) 1978-10-10
FR2190440A1 (sv) 1974-02-01
FR2190440B1 (sv) 1976-09-03
DK141531B (da) 1980-04-14
CS191212B2 (en) 1979-06-29
NL178256C (nl) 1986-02-17
CA994342A (en) 1976-08-03
NO133670B (sv) 1976-03-01

Similar Documents

Publication Publication Date Title
SE407579B (sv) Forfarande for framstellning av n-fosfonometylglycin
SE398229B (sv) Forfarande for framstellning av 4-fenoxi-fenoxialkankarbonsyraderivat
SE417430B (sv) Forfarande for framstellning av o-substituerade 7beta-amino-3-cefem-3-ol-4-karboxylsyraforeningar
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE7700442L (sv) Forfarande for framstellning av 6-aminopenicillansyra
SE386892B (sv) Forfarande for framstellning av oxaminoforeningar
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
SE385698B (sv) Forfarande for framstellning av kinolinettiksyraderivat
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
SE392609B (sv) Forfarande for framstellning av metanhaltiga gaser
SE383151B (sv) Forfarande for framstellning av 1-hydroxi-2-pyridoner
SE399708B (sv) Forfarande for framstellning av tioxanton-2-karboxylsyraderivat
SE402009B (sv) Forfarande for framstellning av 9-desoxi-prosta-5,9,(10),13-triensyraderivat
SE421424B (sv) Analogiforfarande for framstellning av lysergsyraamider
SE393111B (sv) Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE393808B (sv) Forfarande for framstellning av isomaltit
SE415355B (sv) Forfarande for framstellning av fosfonotioureider
NO142307C (no) Fremgangsmaate ved fremstilling av pregnansyrederivater
SE391717B (sv) Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner
NO140736C (no) Fremgangsmaate til fremstilling av poly-alfa-oksyakrylsyre
NO136750C (no) Fremgangsm}te for fremstilling av indanderivater
SE389862B (sv) Forfarande for framstellning av alfa-6-deoxitetracykliner